2024-12-31
0000059478
us-gaap:NonUsMember
lly:ImmunologyMember
2023-01-01
2023-12-31
0000059478
us-gaap:NonUsMember
lly:ImmunologyMember
2022-01-01
2022-12-31
0000059478
country:US
lly:EmgalityMember
2024-01-01
2024-12-31
0000059478
country:US
lly:EmgalityMember
2023-01-01
2023-12-31
0000059478
country:US
lly:EmgalityMember
2022-01-01
2022-12-31
0000059478
us-gaap:NonUsMember
lly:EmgalityMember
2024-01-01
2024-12-31
0000059478
us-gaap:NonUsMember
lly:EmgalityMember
2023-01-01
2023-12-31
0000059478
us-gaap:NonUsMember
lly:EmgalityMember
2022-01-01
2022-12-31
0000059478
country:US
lly:ZyprexaMember
2024-01-01
2024-12-31
0000059478
country:US
lly:ZyprexaMember
2023-01-01
2023-12-31
0000059478
country:US
lly:ZyprexaMember
2022-01-01
2022-12-31
0000059478
us-gaap:NonUsMember
lly:ZyprexaMember
2024-01-01
2024-12-31
0000059478
us-gaap:NonUsMember
lly:ZyprexaMember
2023-01-01
2023-12-31
0000059478
us-gaap:NonUsMember
lly:ZyprexaMember
2022-01-01
2022-12-31
0000059478
country:US
lly:OtherNeuroscienceMember
2024-01-01
2024-12-31
0000059478
country:US
lly:OtherNeuroscienceMember
2023-01-01
2023-12-31
0000059478
country:US
lly:OtherNeuroscienceMember
2022-01-01
2022-12-31
0000059478
us-gaap:NonUsMember
lly:OtherNeuroscienceMember
2024-01-01
2024-12-31
0000059478
us-gaap:NonUsMember
lly:OtherNeuroscienceMember
2023-01-01
2023-12-31
0000059478
us-gaap:NonUsMember
lly:OtherNeuroscienceMember
2022-01-01
2022-12-31
0000059478
country:US
lly:NeuroscienceMember
2024-01-01
2024-12-31
0000059478
country:US
lly:NeuroscienceMember
2023-01-01
2023-12-31
0000059478
country:US
lly:NeuroscienceMember
2022-01-01
2022-12-31
0000059478
us-gaap:NonUsMember
lly:NeuroscienceMember
2024-01-01
2024-12-31
0000059478
us-gaap:NonUsMember
lly:NeuroscienceMember
2023-01-01
2023-12-31
0000059478
us-gaap:NonUsMember
lly:NeuroscienceMember
2022-01-01
2022-12-31
0000059478
country:US
lly:COVID19AntibodiesMember
2024-01-01
2024-12-31
0000059478
country:US
lly:COVID19AntibodiesMember
2023-01-01
2023-12-31
0000059478
country:US
lly:COVID19AntibodiesMember
2022-01-01
2022-12-31
0000059478
us-gaap:NonUsMember
lly:COVID19AntibodiesMember
2024-01-01
2024-12-31
0000059478
us-gaap:NonUsMember
lly:COVID19AntibodiesMember
2023-01-01
2023-12-31
0000059478
us-gaap:NonUsMember
lly:COVID19AntibodiesMember
2022-01-01
2022-12-31
0000059478
country:US
lly:OtherProductMember
2024-01-01
2024-12-31
0000059478
country:US
lly:OtherProductMember
2023-01-01
2023-12-31
0000059478
country:US
lly:OtherProductMember
2022-01-01
2022-12-31
0000059478
us-gaap:NonUsMember
lly:OtherProductMember
2024-01-01
2024-12-31
0000059478
us-gaap:NonUsMember
lly:OtherProductMember
2023-01-01
2023-12-31
0000059478
us-gaap:NonUsMember
lly:OtherProductMember
2022-01-01
2022-12-31
0000059478
country:US
lly:OtherProductTotalMember
2024-01-01
2024-12-31
0000059478
country:US
lly:OtherProductTotalMember
2023-01-01
2023-12-31
0000059478
country:US
lly:OtherProductTotalMember
2022-01-01
2022-12-31
0000059478
us-gaap:NonUsMember